Welcome to TrialPath Clinical

Accelerating Clinical Research Across Africa With Precision, Reliability & Global Standards

TrialPath Clinical is a full-service CRO delivering end-to-end clinical trial solutions across Sub-Saharan Africa. We support pharmaceutical, biotech, academic, and global health organizations with high-quality, GCP-aligned research from concept development to study close-out.

Why Choose TrialPath Clinical

Your Strategic CRO Partner in Africa

TrialPath Clinical bridges scientific innovation with deep regional expertise, enabling sponsors to run fast, compliant, and operationally efficient trials in Africa.

Full ICH-GCP Compliance

GCP-aligned systems, validated processes, and audit-ready documentation.

Accelerated Study Start-Up

Rapid feasibility, regulatory submissions, and ethics approvals.

Expert Clinical Teams

Experienced CRAs, PMs, lab specialists & regulatory experts.

Africa-Focused Capabilities

Local insight + international standards = powerful results.

Regulatory & Quality Strength

Zero critical findings in recent audits; robust QA oversight.

Strong Site Networks

Over 30 high-performing study sites across East & West Africa.

We maintain the highest standards of regulatory compliance across all jurisdictions, ensuring your trials meet global requirements

TrialPath Clinical Services

End-to-End Clinical Trial Excellence

We provide comprehensive services across the clinical research lifecycle:

Scientific Integrity

Innovation Excellence

25+

Partners & Clients

Real-World Case Studies Driving Scientific Advancement

Early Phase Development

Clinical Trial Design & Protocol Development

Our team of experienced scientists and clinicians collaborates with sponsors to develop scientifically sound and operationally efficient clinical trial protocols. We focus on optimizing study endpoints, patient populations, and statistical methodologies to ensure high-quality data and successful outcomes. From Phase I to Phase IV, we cover all therapeutic areas.

Regulatory Compliance

Regulatory Affairs & Submissions

TialPath Research Solutions provides comprehensive regulatory strategy and submission services. We assist with IND/CTA applications, NDA/BLA/MAA submissions, and post-marketing commitments across major health authorities (FDA, EMA, PMDA, etc.). Our experts ensure all documentation meets stringent requirements, minimizing delays and maximizing approval potential.

Clinical Operations

Patient Recruitment & Retention

Successful clinical trials depend on effective patient enrollment. We employ data-driven approaches, digital outreach, community engagement, and site-specific strategies to identify and recruit diverse patient populations. Our retention programs focus on patient support and communication to minimize dropout rates and ensure study completion.

Data & Analytics

Data Management & Biostatistics

Our data management services ensure the collection, cleaning, and validation of high-quality clinical data using industry-leading EDC systems. Coupled with our biostatistics expertise, we provide comprehensive statistical programming, analysis, and reporting, transforming raw data into actionable insights that support critical decision-making.

Post-Market Surveillance

Pharmacovigilance & Drug Safety

TialPath Research Solutions offers robust pharmacovigilance services, including adverse event collection, causality assessment, expedited reporting, and aggregate report generation (PSURs, DSURs). We establish and maintain global safety databases, ensuring compliance with international regulations and safeguarding patient well-being.

Clinical Operations

Clinical Site Management & Monitoring

Our Clinical Research Associates (CRAs) provide meticulous site selection, initiation, routine monitoring, and close-out activities. We ensure adherence to protocols, Good Clinical Practice (GCP), and regulatory requirements, fostering strong relationships with investigators and site staff to drive efficient trial execution and high-quality data collection.

Early Phase Development

Phase I Clinical Trials

Our Phase I clinical trial services focus on meticulously evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of novel compounds in healthy volunteers or specific patient populations. We leverage state-of-the-art facilities and experienced medical staff to ensure precise data collection and patient well-being, adhering to the highest ethical standards and regulatory guidelines.

Late Phase Development

Phase II/III Clinical Trials

TialPath Research Solutions excels in managing complex Phase II and III clinical trials, designed to demonstrate the efficacy and further assess the safety of investigational drugs. Our global network of trial centers, advanced patient recruitment strategies, and rigorous data management ensure high-quality results that support regulatory submissions and market access. We focus on therapeutic areas including oncology, neurology, and rare diseases.

Therapeutic Focus

Areas of Expertise

Deep scientific and operational knowledge across a wide spectrum of therapeutic areas.

Oncology

Oncology Clinical Trials

Leading innovative research in cancer therapies, from early-phase development to post-market surveillance.

Cardiology

Cardiovascular Disease Research

Our cardiovascular expertise spans a broad range of indications, including heart failure, hypertension, atherosclerosis, and arrhythmias.

Rare Diseases

Rare Disease & Orphan Drug Development

Our team possesses deep understanding of regulatory pathways for orphan drugs, patient advocacy engagement, and adaptive trial designs.